- Business Model
- B2B
About
Biotech company; KOSDAQ IPO
Summary
Genome & Company is a Biotech company based in South Korea.
Similar Companies
Ultima Genomics
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Fremont, United States201–500Artificial Intelligence, Healthcare
Series E·$1.1B·Jun 2022
Alnylam PharmaceuticalsIPO
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Cambridge, United States1001–5000Biotech, Genomics
Corporate Round·$1.0B·Apr 2020
Pacific Biosciences
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Menlo Park, United States501–1000Biotech, Genomics
Convertible·$900.0M·Feb 2021
GRAILIPO
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Menlo Park, United States1001–5000Biotech, Genomics
Corporate Round·$835.0M·Jun 2026
Tessera Therapeutics
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Somerville, United States201–500Biotech, Genomics
Corporate Round·$730.0M·Dec 2025
Mirador Therapeutics
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego, United States11–50Biotech, Drug Discovery
Series B·$650.0M·Oct 2025